Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
The Anti-dementia Drug Candidate, (-)-Clausenamide, Improves Memory Impairment through its Multi-target Effect.
Transverse Myelitis in Acute Hepatitis A Infection: The Rare Co-Occurrence of Hepatology and Neurology.
Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein.
Neuron-Microglia Interaction Induced Bi-directional Cytotoxicity Associated with Calpain Activation.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.
Treatment for Krabbe's disease: Finding the combination.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients.
Idiopathic Transverse Myelitis Mimicking an Intramedullary Spinal Cord Tumor.
Non-human Immunodeficiency Virus-related Ocular Syphilis in a Korean Population: Clinical Manifestations and Treatment Outcomes.
Impaired oligodendroglial turnover is associated with myelin pathology in Focal Cortical Dysplasia and Tuberous Sclerosis Complex.
Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke.
Multiple sclerosis patients need and want information on exercise promotion from healthcare providers: a qualitative study.
Natalizumab: a new therapy for acute ischemic stroke?
Neuropathic pruritus as the p]resenting symptom of lupus transverse myelitis.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
A Novel Transgenic Mouse Model of Lysosomal Storage Disorder.
Protective effects of BMP-7 against tumor necrosis factor α-induced oligodendrocyte apoptosis.
Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.
Pages
« first
‹ previous
…
812
813
814
815
816
817
818
819
820
…
next ›
last »